4.7 Review

Incorporating neglected non-communicable diseases into the national health program-A review

Journal

FRONTIERS IN PUBLIC HEALTH
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fpubh.2022.1093170

Keywords

non-communicable disease (NCD); diabetes; hypertension; NCD and risk factors; NCD burden; neglected disease initiative; neglected NCD

Ask authors/readers for more resources

Poor nations are facing the burden of both communicable and non-communicable diseases, with neglected non-communicable diseases becoming a major public health challenge. The BIG FOUR NCDs, including diabetes, cancer, chronic respiratory diseases, and cardiovascular diseases, are recognized as the main contributors to global health loss. However, other NCDs are often neglected despite accounting for a significant portion of the global burden of NCDs. This paper briefly discusses the disease burden of some significant yet neglected NCDs.
Poor nations are already facing the heat of double burden of communicable and non-communicable diseases (NCDs), often known as chronic illnesses, which are characterized by a protracted course and are multifactorial in causation. In addition to this, neglected non-communicable diseases (NNCD) in the form of gout, sickle cell disease, accidents and many more are likely to be one of the biggest public health challenges soon. Nearly three-quarters (31.4 million) of all NCD-related fatalities occur in developing nations. In terms of morbidity and mortality, the BIG FOUR NCDs-diabetes, cancer, chronic respiratory diseases, and cardiovascular diseases-are widely acknowledged as the main contributors to global health loss. However, other NCDs account for 55% of the global burden of NCDs and are frequently neglected in terms of premature death, increased Disability Adjusted Life Years (DALY), and decreased Quality-Adjusted Life Year (QALY). We have briefly discussed the disease burden of a few significant, yet neglected NCDs in this paper.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available